NCT01511172 - Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

145

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

liraglutide

Individually adjusted dose, maximum 2.0 mg. Injected subcutaneously

DRUG

metformin

1000 mg daily, administered orally

DRUG

placebo

Metformin placebo administered orally. 1000 mg daily

DRUG

placebo

NNC 90-1170 placebo. Individually adjusted dose, maximum 2.0 mg. Injected subcutaneously

DRUG

glimepiride

Individually adjusted dose, administered orally

Trial Locations (41)

1030

Novo Nordisk Investigational Site, Vienna

2000

Novo Nordisk Investigational Site, Frederiksberg

2400

Novo Nordisk Investigational Site, Copenhagen

2605

Novo Nordisk Investigational Site, Garran

4600

Novo Nordisk Investigational Site, Køge

5035

Novo Nordisk Investigational Site, Ashford

5041

Novo Nordisk Investigational Site, Daw Park

7700

Novo Nordisk Investigational Site, Thisted

8000

Novo Nordisk Investigational Site, Århus C

10034

Novo Nordisk Investigational Site, Prague

11108

Novo Nordisk Investigational Site, Narbonne

12203

Novo Nordisk Investigational Site, Berlin

17019

Novo Nordisk Investigational Site, La Rochelle

37001

Novo Nordisk Investigational Site, České Budějovice

37431

Novo Nordisk Investigational Site, Bad Lauterberg im Harz

41460

Novo Nordisk Investigational Site, Neuss

44791

Novo Nordisk Investigational Site, Bochum

58033

Novo Nordisk Investigational Site, Nevers

67675

Novo Nordisk Investigational Site, Kaiserslautern

68167

Novo Nordisk Investigational Site, Mannheim

75475

Novo Nordisk Investigational Site, Paris

79106

Novo Nordisk Investigational Site, Freiburg im Breisgau

SA 5035

Novo Nordisk Investigational Site, Adelaide

A 1090

Novo Nordisk Investigational Site, Vienna

A-1130

Novo Nordisk Investigational Site, Vienna

96-200

Novo Nordisk Investigational Site, Rawa Mazowiecka

41-800

Novo Nordisk Investigational Site, Zabrze

KT15 2BH

Novo Nordisk Investigational Site, Addlestone

HP21 7TL

Novo Nordisk Investigational Site, Aylesbury

S70 3RJ

Novo Nordisk Investigational Site, Barnsley

TN39 4SP

Novo Nordisk Investigational Site, Bexhill-on-Sea

NP18 1AZ

Novo Nordisk Investigational Site, Caerleon

GU15 2NN

Novo Nordisk Investigational Site, Camberley

SN15 1HP

Novo Nordisk Investigational Site, Chippenham

KT24 6QT

Novo Nordisk Investigational Site, East Horsley

BA11 1EZ

Novo Nordisk Investigational Site, Frome

Unknown

Novo Nordisk Investigational Site, Magherafelt

S3 9DA

Novo Nordisk Investigational Site, Sheffield

CB7 5JD

Novo Nordisk Investigational Site, Soham

TW16 6RH

Novo Nordisk Investigational Site, Sunbury-on-Thames

PE7 3JL

Novo Nordisk Investigational Site, Yaxley. Peterborough